Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Long-Term Investments (2010 - 2026)

Geron (GERN) posted Long-Term Investments of $26.7 million for Q1 2026, down 35.37% sequentially from $41.3 million in Q4 2025, and down 54.61% YoY from $58.8 million in Q1 2025.

Geron (GERN) Long-Term Investments (2010 - 2026) Analysis & Trends

Geron has reported Long-Term Investments for 16 years, with the latest figure at $26.7 million in Q1 2026.

  • Quarterly Long-Term Investments fell 54.61% year-over-year to $26.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.7 million (down 54.61% YoY) and the FY2025 annual result came in at $41.3 million, down 56.32% from the prior year.
  • Long-Term Investments eased to $26.7 million in Q1 2026 per GERN's latest filing, from $41.3 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $94.5 million in Q4 2024 and troughed at $364000.0 in Q2 2022.
  • A 5-year average of $27.8 million and a median of $26.7 million in 2026 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2022 and 2023: Long-Term Investments sank 99.1% in 2022, then surged 18532.14% in 2023.
  • Over 5 years, Long-Term Investments stood at $364000.0 in 2022, then surged by 206.32% to $1.1 million in 2023, then surged by 8377.04% to $94.5 million in 2024, then sank by 56.32% to $41.3 million in 2025, then tumbled by 35.37% to $26.7 million in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $26.7 million, $41.3 million, and $39.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.77 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 22.17 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 372.10 Mn
10 Geron 1.02 Mn -299.83 Mn - 24.12 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 24.12 Mn
Mar 31, 2026 26.69 Mn
Dec 31, 2025 41.29 Mn
Sep 30, 2025 39.06 Mn
Jun 30, 2025 42.74 Mn
Mar 31, 2025 58.80 Mn
Dec 31, 2024 94.52 Mn
Sep 30, 2024 37.31 Mn
Jun 30, 2024 1.12 Mn
Mar 31, 2024 20.78 Mn
Dec 31, 2023 1.12 Mn
Sep 30, 2023 67.82 Mn
Jun 30, 2023 535,000.00
Mar 31, 2023 28.10 Mn
Dec 31, 2022 364,000.00
Sep 30, 2022 364,000.00
Jun 30, 2022 364,000.00
Mar 31, 2022 10.95 Mn
Dec 31, 2021 28.65 Mn
Sep 30, 2021 39.36 Mn